Grimes & Company’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.65M | Buy |
|
|||||
|
2025
Q1 | $7.43M | Buy |
|
|||||
|
2024
Q4 | $8.92M | Sell |
|
|||||
|
2024
Q3 | $12.6M | Sell |
|
|||||
|
2024
Q2 | $15.3M | Buy |
|
|||||
|
2024
Q1 | $13.6M | Buy |
|
|||||
|
2023
Q4 | $10.6M | Buy |
|
|||||
|
2023
Q3 | $9.17M | Sell |
|
|||||
|
2023
Q2 | $8.66M | Buy |
|
|||||
|
2023
Q1 | $8.47M | Sell |
|
|||||
|
2022
Q4 | $10.8M | Buy |
|
|||||
|
2022
Q3 | $7.82M | Sell |
|
|||||
|
2022
Q2 | $8.92M | Sell |
|
|||||
|
2022
Q1 | $12.2M | Sell |
|
|||||
|
2021
Q4 | $19.9M | Sell |
|
|||||
|
2021
Q3 | $17.1M | Sell |
|
|||||
|
2021
Q2 | $15.3M | Buy |
|
|||||
|
2021
Q1 | $12.2M | Buy |
|
|||||
|
2020
Q4 | $11.2M | Buy |
|
|||||
|
2020
Q3 | $10.6M | Sell |
|
|||||
|
2020
Q2 | $13M | Sell |
|
|||||
|
2020
Q1 | $12.2M | Sell |
|
|||||
|
2019
Q4 | $12.1M | Sell |
|
|||||
|
2019
Q3 | $11.1M | Buy |
|
|||||
|
2019
Q2 | $10.8M | Buy |
|
|||||
|
2019
Q1 | $11M | Buy |
|
|||||
|
2018
Q4 | $9.46M | Buy |
|
|||||
|
2018
Q3 | $9.65M | Buy |
|
|||||
|
2018
Q2 | $9.06M | Sell |
|
|||||
|
2018
Q1 | $9.78M | Sell |
|
|||||
|
2017
Q4 | $10.7M | Sell |
|
|||||
|
2017
Q3 | $9.76M | Sell |
|
|||||
|
2017
Q2 | $8.83M | Sell |
|
|||||
|
2017
Q1 | $7.76M | Buy |
|
|||||
|
2016
Q4 | $3.38M | Sell |
|
|||||
|
2016
Q3 | $8M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $237K | Hold |
|
|||||
|
2015
Q4 | $254K | Sell |
|
|||||
|
2015
Q3 | $241K | Sell |
|
|||||
|
2015
Q2 | $395K | Sell |
|
|||||
|
2015
Q1 | $9.21M | Buy |
|
|||||
|
2014
Q4 | $6.87M | Buy |
|
|||||
|
2014
Q3 | $7.71M | Buy |
|
|||||
|
2014
Q2 | $7.45M | Buy |
|
|||||
|
2014
Q1 | $7.17M | Sell |
|
|||||
|
2013
Q4 | $5.81M | Buy |
|
|||||
|
2013
Q3 | $4.78M | Buy |
|
|||||
|
2013
Q2 | $3.87M | Buy |
|